Aquaporin-4 downregulation in dysphagic patients with idiopathic inflammatory myopathies: myofiber vulnerability and inflammation drivers. [PDF]
Fornaro M +9 more
europepmc +1 more source
Immune Characterization of a Vietnamese Cohort With Idiopathic Inflammatory Myopathies. [PDF]
Luo YB +8 more
europepmc +1 more source
Recent advances in immunological mechanisms and murine disease models of idiopathic inflammatory myopathies. [PDF]
Nishidate A +3 more
europepmc +1 more source
Juvenile idiopathic inflammatory myopathies assessment by magnetic resonance imaging: a scoping review of protocols, scoring systems, and applications. [PDF]
Paula VT +15 more
europepmc +1 more source
Tacrolimus as first-line therapy in a US cohort of idiopathic inflammatory myopathies related interstitial lung disease. [PDF]
Harris KJR +5 more
europepmc +1 more source
Immunoadsorption as a novel therapy for refractory idiopathic inflammatory myopathies: a retrospective observational study. [PDF]
Kastrati K +13 more
europepmc +1 more source
Case Report: Telitacicept for interstitial lung disease associated with idiopathic inflammatory myopathies: an observational study. [PDF]
Chen X +6 more
europepmc +1 more source
AI-based chest CT quantification of interstitial lung disease in idiopathic inflammatory myopathies: agreement with expert visual assessment in 107 patients. [PDF]
Kuzmanovic Y +12 more
europepmc +1 more source
Is Hydroxychloroquine Useful for the Treatment of Cutaneous Manifestations of Idiopathic Inflammatory Myopathies? A Systematic Review. [PDF]
Gonçalves Júnior J +2 more
europepmc +1 more source
Cardiovascular risk and lipid-lowering therapy in idiopathic inflammatory myopathies: a call for improved, disease-specific risk assessment. [PDF]
Loh K, Rose E, Tansley S.
europepmc +1 more source

